Nectar Lifesciences Limited

NSEI:NECLIFE Stok Raporu

Piyasa değeri: ₹8.7b

Nectar Lifesciences Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Nectar Lifesciences şirketinin toplam hissedar öz sermayesi ₹10.7B ve toplam borcu ₹6.4B olup, bu da borç-öz sermaye oranını 59.4% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ₹21.9B ve ₹11.2B dir. Nectar Lifesciences 'in FAVÖK'ü ₹969.8M faiz karşılama oranı 1.2 dur. Şirketin ₹203.0M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

59.4%

Borç/özkaynak oranı

₹6.36b

Borç

Faiz karşılama oranı1.2x
Nakit₹203.01m
Eşitlik₹10.69b
Toplam yükümlülükler₹11.22b
Toplam varlıklar₹21.91b

Son finansal sağlık güncellemeleri

Recent updates

Revenues Working Against Nectar Lifesciences Limited's (NSE:NECLIFE) Share Price Following 26% Dive

Oct 11
Revenues Working Against Nectar Lifesciences Limited's (NSE:NECLIFE) Share Price Following 26% Dive

Nectar Lifesciences Limited (NSE:NECLIFE) Shares Fly 31% But Investors Aren't Buying For Growth

Aug 22
Nectar Lifesciences Limited (NSE:NECLIFE) Shares Fly 31% But Investors Aren't Buying For Growth

Here's Why Nectar Lifesciences (NSE:NECLIFE) Has A Meaningful Debt Burden

Jul 27
Here's Why Nectar Lifesciences (NSE:NECLIFE) Has A Meaningful Debt Burden

Nectar Lifesciences Limited (NSE:NECLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Feb 19
Nectar Lifesciences Limited (NSE:NECLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?

Dec 22
Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?

Nectar Lifesciences (NSE:NECLIFE) Has Debt But No Earnings; Should You Worry?

Jun 16
Nectar Lifesciences (NSE:NECLIFE) Has Debt But No Earnings; Should You Worry?

Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt

Jun 21
Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt

Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt

Jul 29
Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt

Is Nectar Lifesciences Limited (NSE:NECLIFE) A Risky Dividend Stock?

Feb 25
Is Nectar Lifesciences Limited (NSE:NECLIFE) A Risky Dividend Stock?

Nectar Lifesciences (NSE:NECLIFE) Has A Somewhat Strained Balance Sheet

Jan 21
Nectar Lifesciences (NSE:NECLIFE) Has A Somewhat Strained Balance Sheet

Zooming in on NSE:NECLIFE's 0.3% Dividend Yield

Nov 02
Zooming in on NSE:NECLIFE's 0.3% Dividend Yield

Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?

Sep 07
Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?

If You Had Bought Nectar Lifesciences (NSE:NECLIFE) Stock A Year Ago, You Could Pocket A 47% Gain Today

Aug 09
If You Had Bought Nectar Lifesciences (NSE:NECLIFE) Stock A Year Ago, You Could Pocket A 47% Gain Today

The Nectar Lifesciences (NSE:NECLIFE) Share Price Has Gained 47% And Shareholders Are Hoping For More

Aug 09
The Nectar Lifesciences (NSE:NECLIFE) Share Price Has Gained 47% And Shareholders Are Hoping For More

What You Can Learn From Nectar Lifesciences Limited's (NSE:NECLIFE) P/E

Jul 13
What You Can Learn From Nectar Lifesciences Limited's (NSE:NECLIFE) P/E

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: NECLIFE 'nin kısa vadeli varlıkları ( ₹12.8B ) kısa vadeli yükümlülüklerini ( ₹9.7B ) aşıyor.

Uzun Vadeli Yükümlülükler: NECLIFE şirketinin kısa vadeli varlıkları ( ₹12.8B ) uzun vadeli yükümlülüklerini ( ₹1.5B ) aşmaktadır.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: NECLIFE 'nin net borç/öz sermaye oranı ( 57.5% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: NECLIFE 'nin borç/öz sermaye oranı son 5 yılda 82.8% seviyesinden 59.4% seviyesine düştü.

Borç Kapsamı: NECLIFE 'nin borcu işletme nakit akışı ( 35.4% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: NECLIFE 'in borcuna ilişkin faiz ödemeleri EBIT ( 1.2 x kapsam) tarafından iyi karşılanmıyor.


Bilanço


Sağlıklı şirketleri keşfedin